- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
-
- 长期趋势：
已有18家主力机构披露2024-12-31报告期持股数据，持仓量总计117.24万股，占流通A股0.44%
- 波段诊断：
-
技术面诊股
诊断结果：4.2技术面打败了81%的股票
技术面评分前10的股票
近期的平均成本为14.72元。
平均成本
近期的平均成本为14.72元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.72","date":1743408947,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，跑赢行业平均水平。
[{"date":"2025.04.01","stock":"3.16","trade":null,"ind":"-0.01"},{"date":"2025.03.31","stock":"-5.81","trade":null,"ind":"-0.97"},{"date":"2025.03.28","stock":"11.87","trade":null,"ind":"-0.57"},{"date":"2025.03.27","stock":"-2.51","trade":null,"ind":"0.23"},{"date":"2025.03.26","stock":"-1.45","trade":null,"ind":"-0.05"},{"date":"2025.03.25","stock":"1.70","trade":null,"ind":"-0.43"},{"date":"2025.03.24","stock":"4.23","trade":null,"ind":"0.07"},{"date":"2025.03.21","stock":"-2.62","trade":null,"ind":"-1.76"},{"date":"2025.03.20","stock":"-0.37","trade":null,"ind":"-0.91"},{"date":"2025.03.19","stock":"1.67","trade":null,"ind":"-0.32"},{"date":"2025.03.18","stock":"0.15","trade":null,"ind":"0.52"},{"date":"2025.03.17","stock":"-1.35","trade":null,"ind":"-0.19"},{"date":"2025.03.14","stock":"1.76","trade":null,"ind":"2.26"},{"date":"2025.03.13","stock":"-0.76","trade":null,"ind":"-0.99"},{"date":"2025.03.12","stock":"1.30","trade":null,"ind":"-0.17"},{"date":"2025.03.11","stock":"-0.76","trade":null,"ind":"0.33"},{"date":"2025.03.10","stock":"-0.98","trade":null,"ind":"-0.17"},{"date":"2025.03.07","stock":"-1.04","trade":null,"ind":"-0.50"},{"date":"2025.03.06","stock":"2.76","trade":null,"ind":"1.77"},{"date":"2025.03.05","stock":"0.31","trade":null,"ind":"0.28"},{"date":"2025.03.04","stock":"3.42","trade":null,"ind":"0.28"}]
冠昊生物,深证成指,医疗器械指数
压力支撑
该股压力位为14.62元，支撑位为14.09元。
[{"text":"\u538b\u529b\u4f4d","value":"14.62","date":1743436800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.09","date":1743436800,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.0资金面打败了11%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：04月01日 20:30
| 机构今日流向(万元) | 2089.36 | 机构5日流向(万元) | 1302.86 |
| 机构10日流向(万元) | -2806.82 | 机构20日流向(万元) | -7288.44 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少7446.68万股，其中基金净减仓1家，主力净减仓5家，请投资者中长期谨慎为宜。
截止2024-12-31，共18家主力机构（基金18家），持仓量总计117.24万股，占流通A股0.44%
其中，基金持仓与2024-06-30相比：
增仓：6家 ，增持 2.98万股
减仓：7家 ，减持 2.22万股
新出现在主力名单中：4家 ，持有16.82万股
从主力名单中消失：9家 ，原持有7464.26万股
其中，基金持仓与2024-06-30相比：
增仓：6家 ，增持 2.98万股
减仓：7家 ，减持 2.22万股
新出现在主力名单中：4家 ，持有16.82万股
从主力名单中消失：9家 ，原持有7464.26万股
消息面诊股
诊断结果：5.5消息面打败了35%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 创新药“扬帆出海”，海外市场成为药企新大陆
2025-03-31 - 行业周报|医疗器械指数跌-0.48%, 跑输上证指
2025-03-28 - 创新药将迎来春天？网红私募：2025年创新药，就是
2025-03-28 - 多家港股创新药企2024年业绩爆发，医药50ETF
2025-03-28 - 冠昊生物等创新药股：3 月 28 日大幅拉升
2025-03-28 - 创新药概念股大涨 冠昊生物直线拉升录得20cm涨停
2025-03-28 - 涨停雷达：再生医学材料+细胞免疫治疗+创新药 冠昊
2025-03-28 - 冠昊生物：3月31日将召开2025年第一次临时股东
2025-03-26 - 冠昊生物（截止2025年3月20日）股东人数为28
2025-03-25 - 冠昊生物：公司暂无辅助生殖相关业务
2025-03-25
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-03-14 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-02-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-02-24 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-01-24 |
| 一般消息 | 高管变动 | 为更好地履行董事长职责，将更多精力... | 2025-01-10 |
| 一般消息 | 资产重组 | 公司股权转让 | 2024-12-11 |
| 一般消息 | 资产重组 | 公司股权转让 | 2024-11-12 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-28 |
| 一般消息 | 高管变动 | 工作调整 | 2024-07-29 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2024-04-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-04-10 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了57%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2025.04.01","price":"-0.01","value":null},{"date":"2025.03.31","price":"-0.97","value":null},{"date":"2025.03.28","price":"-0.57","value":null},{"date":"2025.03.27","price":"0.23","value":null},{"date":"2025.03.26","price":"-0.05","value":null},{"date":"2025.03.25","price":"-0.43","value":null},{"date":"2025.03.24","price":"0.07","value":null},{"date":"2025.03.21","price":"-1.76","value":null},{"date":"2025.03.20","price":"-0.91","value":null},{"date":"2025.03.19","price":"-0.32","value":null},{"date":"2025.03.18","price":"0.52","value":null},{"date":"2025.03.17","price":"-0.19","value":null},{"date":"2025.03.14","price":"2.26","value":null},{"date":"2025.03.13","price":"-0.99","value":null},{"date":"2025.03.12","price":"-0.17","value":null},{"date":"2025.03.11","price":"0.33","value":null},{"date":"2025.03.10","price":"-0.17","value":null},{"date":"2025.03.07","price":"-0.50","value":null},{"date":"2025.03.06","price":"1.77","value":null},{"date":"2025.03.05","price":"0.28","value":null},{"date":"2025.03.04","price":"0.28","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 热景生物 | 57.87% | 33.45% | 4.8分 |
| 2 | 怡和嘉业 | 22.58% | 16.87% | 4.8分 |
| 3 | 中源协和 | 14.72% | 7.97% | 5.1分 |
| 4 | 麦澜德 | 14.68% | -0.73% | 3.8分 |
| 5 | 山外山 | 13.02% | 5.64% | 4.9分 |
| 6 | 华兰股份 | 12.96% | -1.54% | 3.1分 |
| 8 | 冠昊生物 | 10.62% | 4.43% | 4.2分 |
| 10 | 爱博医疗 | 9.86% | 8.91% | 5.5分 |
| 12 | 迈普医学 | 8.68% | 8.70% | 5.1分 |
| 14 | 奕瑞科技 | 8.48% | 10.32% | 5.3分 |
| 16 | 春立医疗 | 7.80% | 10.57% | 5.1分 |
| 18 | 三鑫医疗 | 6.97% | 4.10% | 4.8分 |
| 20 | 澳华内镜 | 6.68% | 1.76% | 4.6分 |
| 22 | 硕世生物 | 6.08% | 0.41% | 4.0分 |
| 24 | 威高骨科 | 5.14% | 6.24% | 5.5分 |
| 26 | 赛诺医疗 | 4.43% | 2.03% | 5.4分 |
| 28 | 易瑞生物 | 4.11% | 3.05% | 3.6分 |
| 30 | 黄山胶囊 | 3.53% | 2.58% | 4.0分 |
| 32 | 迈克生物 | 3.14% | 0.30% | 3.6分 |
| 34 | 健帆生物 | 3.01% | 1.29% | 5.0分 |
| 36 | 爱迪特 | 2.82% | 3.34% | 4.2分 |
| 38 | 奥美医疗 | 2.33% | 3.24% | 5.3分 |
| 40 | 安旭生物 | 2.24% | 0.34% | 4.7分 |
| 42 | 康德莱 | 1.73% | 3.79% | 4.9分 |
| 44 | 美好医疗 | 1.46% | 3.22% | 4.5分 |
| 46 | 山东药玻 | 1.15% | -0.34% | 5.2分 |
| 48 | 之江生物 | 0.92% | 3.46% | 3.5分 |
| 50 | 乐普医疗 | 0.51% | 2.86% | 4.0分 |
| 52 | 天臣医疗 | 0.26% | 5.97% | 5.0分 |
| 54 | 万孚生物 | 0.21% | 1.71% | 3.8分 |
| 56 | 翔宇医疗 | -0.05% | 3.94% | 3.5分 |
| 58 | 明德生物 | -0.16% | 1.02% | 4.4分 |
| 60 | 中红医疗 | -0.40% | 1.22% | 4.3分 |
| 62 | 东星医疗 | -0.58% | 2.97% | 3.6分 |
| 64 | 英科医疗 | -0.72% | 1.19% | 4.3分 |
| 66 | 透景生命 | -0.79% | 1.70% | 3.5分 |
| 68 | 健尔康 | -0.89% | 1.99% | 4.4分 |
| 70 | 拱东医疗 | -1.28% | 0.57% | 5.2分 |
| 72 | 华强科技 | -1.37% | -0.99% | 3.6分 |
| 74 | 昊海生科 | -1.42% | 0.43% | 4.6分 |
| 76 | 南微医学 | -1.97% | 1.50% | 5.1分 |
| 78 | 东富龙 | -2.07% | 1.77% | 4.0分 |
| 80 | 楚天科技 | -2.38% | 1.51% | 3.7分 |
| 82 | 宝莱特 | -2.47% | 2.74% | 3.3分 |
| 84 | 科华生物 | -2.96% | 2.07% | 4.0分 |
| 86 | 海泰新光 | -3.04% | -1.02% | 4.2分 |
| 88 | 普门科技 | -3.16% | 2.76% | 5.0分 |
| 90 | 安必平 | -3.41% | 0.22% | 3.6分 |
| 92 | 理邦仪器 | -3.50% | 2.64% | 3.9分 |
| 94 | 蓝帆医疗 | -3.58% | 0.59% | 4.6分 |
| 96 | 迈瑞医疗 | -3.80% | -1.53% | 4.9分 |
| 98 | 奥精医疗 | -4.59% | 1.69% | 3.3分 |
| 100 | 科美诊断 | -4.71% | 1.59% | 4.1分 |
| 102 | 南卫股份 | -5.02% | 3.11% | 3.8分 |
| 104 | 阳普医疗 | -6.00% | 3.20% | 3.9分 |
| 106 | 九强生物 | -6.36% | 2.38% | 4.2分 |
| 108 | 可孚医疗 | -6.74% | 0.71% | 4.3分 |
| 110 | 佰仁医疗 | -7.83% | 2.82% | 4.4分 |
| 112 | 达安基因 | -8.71% | -0.98% | 3.8分 |
| 114 | 天智航 | -9.89% | 0.63% | 3.6分 |
| 116 | - | -10.78% | 12.61% | 分 |
| 118 | 东方生物 | -11.56% | -20.04% | 2.5分 |
| 120 | 济高发展 | -14.69% | -2.85% | 3.5分 |
| 122 | 麦克奥迪 | -17.17% | -2.41% | 3.9分 |
| 124 | 康为世纪 | -22.02% | -2.32% | 2.7分 |
| 126 | 爱朋医疗 | - | 3.65% | 3.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 52/250 ， 8/250。
[{"date":"2024-09-30","value":"5.22","vol":"4.78"},{"date":"2024-06-30","value":"3.80","vol":"3.54"},{"date":"2024-03-31","value":"2.73","vol":"1.67"},{"date":"2023-12-31","value":"6.16","vol":"12.40"},{"date":"2023-09-30","value":"8.14","vol":"5.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.22 | 3.80 | 2.73 | 6.16 | 8.14 |
| 行业(%) | 4.78 | 3.54 | 1.67 | 12.40 | 5.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"78.64","vol":"53.43"},{"date":"2024-06-30","value":"77.82","vol":"53.63"},{"date":"2024-03-31","value":"78.05","vol":"53.16"},{"date":"2023-12-31","value":"79.13","vol":"53.54"},{"date":"2023-09-30","value":"80.42","vol":"53.90"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
78.64 | 77.82 | 78.05 | 79.13 | 80.42 |
| 行业(%) | 53.43 | 53.63 | 53.16 | 53.54 | 53.90 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 96/250 ， 85/250。
[{"date":"2024-09-30","value":"-9.97","vol":"1.29"},{"date":"2024-06-30","value":"-10.02","vol":"0.73"},{"date":"2024-03-31","value":"-18.85","vol":"-0.80"},{"date":"2023-12-31","value":"7.13","vol":"-6.88"},{"date":"2023-09-30","value":"5.09","vol":"-6.02"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-9.97 | -10.02 | -18.85 | 7.13 | 5.09 |
| 行业(%) | 1.29 | 0.73 | -0.80 | -6.88 | -6.02 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-32.55","vol":"-19.70"},{"date":"2024-06-30","value":"-34.46","vol":"9.59"},{"date":"2024-03-31","value":"-34.92","vol":"-15.89"},{"date":"2023-12-31","value":"110.07","vol":"-23.68"},{"date":"2023-09-30","value":"117.82","vol":"0.42"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-32.55 | -34.46 | -34.92 | 110.07 | 117.82 |
| 行业(%) | -19.70 | 9.59 | -15.89 | -23.68 | 0.42 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/250 ， 101/250。
[{"date":"2024-09-30","value":"0.39","vol":"0.26"},{"date":"2024-06-30","value":"0.28","vol":"0.18"},{"date":"2024-03-31","value":"0.13","vol":"0.09"},{"date":"2023-12-31","value":"0.60","vol":"0.37"},{"date":"2023-09-30","value":"0.46","vol":"0.27"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.39 | 0.28 | 0.13 | 0.60 | 0.46 |
| 行业(次) | 0.26 | 0.18 | 0.09 | 0.37 | 0.27 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.81","vol":"1.68"},{"date":"2024-06-30","value":"0.59","vol":"1.13"},{"date":"2024-03-31","value":"0.29","vol":"0.55"},{"date":"2023-12-31","value":"1.27","vol":"2.28"},{"date":"2023-09-30","value":"0.93","vol":"1.59"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.81 | 0.59 | 0.29 | 1.27 | 0.93 |
| 行业(次) | 1.68 | 1.13 | 0.55 | 2.28 | 1.59 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"-2.76","vol":"15.40"},{"date":"2024-06-30","value":"24.33","vol":"12.72"},{"date":"2024-03-31","value":"11.89","vol":"2.14"},{"date":"2023-12-31","value":"-6.04","vol":"39.09"},{"date":"2023-09-30","value":"25.02","vol":"18.01"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -2.76 | 24.33 | 11.89 | -6.04 | 25.02 |
| 行业 | 15.40 | 12.72 | 2.14 | 39.09 | 18.01 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"4.22","vol":"2.32"},{"date":"2024-03-31","value":"","vol":"0.06"},{"date":"2023-12-31","value":"1.54","vol":"2.85"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 4.22 | - | 1.54 | - |
| 行业 | 0.01 | 2.32 | 0.06 | 2.85 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 11/250 ， 4/250。
[{"date":"2024-09-30","value":"1.67","vol":"5.98"},{"date":"2024-06-30","value":"1.79","vol":"5.99"},{"date":"2024-03-31","value":"1.84","vol":"6.56"},{"date":"2023-12-31","value":"1.55","vol":"5.82"},{"date":"2023-09-30","value":"1.91","vol":"6.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.67 | 1.79 | 1.84 | 1.55 | 1.91 |
| 行业 | 5.98 | 5.99 | 6.56 | 5.82 | 6.72 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.07","vol":"4.82"},{"date":"2024-06-30","value":"1.19","vol":"4.93"},{"date":"2024-03-31","value":"1.24","vol":"5.47"},{"date":"2023-12-31","value":"1.04","vol":"4.82"},{"date":"2023-09-30","value":"1.34","vol":"5.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.07 | 1.19 | 1.24 | 1.04 | 1.34 |
| 行业 | 4.82 | 4.93 | 5.47 | 4.82 | 5.64 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 15/250 ， 25/250。
[{"date":"2024-09-30","value":"35.50","vol":"21.14"},{"date":"2024-06-30","value":"32.94","vol":"21.13"},{"date":"2024-03-31","value":"31.88","vol":"20.72"},{"date":"2023-12-31","value":"32.76","vol":"21.25"},{"date":"2023-09-30","value":"30.68","vol":"21.16"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
35.50 | 32.94 | 31.88 | 32.76 | 30.68 |
| 行业(%) | 21.14 | 21.13 | 20.72 | 21.25 | 21.16 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.47","vol":"0.38"},{"date":"2024-06-30","value":"0.42","vol":"0.37"},{"date":"2024-03-31","value":"0.41","vol":"0.37"},{"date":"2023-12-31","value":"0.43","vol":"0.37"},{"date":"2023-09-30","value":"0.39","vol":"0.35"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.47 | 0.42 | 0.41 | 0.43 | 0.39 |
| 行业(%) | 0.38 | 0.37 | 0.37 | 0.37 | 0.35 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2024年的收益，请投资者后续关注。
[{"date":"2020","yellowRectValue":"0.47","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"0.74","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-3.08","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.31","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]